These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31845215)

  • 1. Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk?
    Baldwin DS; Amaro HJF
    CNS Drugs; 2020 Feb; 34(2):163-169. PubMed ID: 31845215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Valproate in Women: An Audit of Prescriptions to 10,001 Psychiatry, Neurology, and Neurosurgery Outpatients.
    Andrade C; Jyothi SA; Renitha T; Anuroopa KP; Dona B; Basila T; Nimmy G
    J Clin Psychiatry; 2021 Nov; 83(1):. PubMed ID: 34813688
    [No Abstract]   [Full Text] [Related]  

  • 4. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
    Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
    Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
    Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
    Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
    Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation.
    Vatzaki E; Straus S; Dogne JM; Garcia Burgos J; Girard T; Martelletti P
    J Headache Pain; 2018 Aug; 19(1):68. PubMed ID: 30109437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Risk for Attention-Deficit/Hyperactivity Disorder in Offspring.
    Christensen J; Pedersen L; Sun Y; Dreier JW; Brikell I; Dalsgaard S
    JAMA Netw Open; 2019 Jan; 2(1):e186606. PubMed ID: 30646190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive review of the psychiatric uses of valproate.
    Davis LL; Ryan W; Adinoff B; Petty F
    J Clin Psychopharmacol; 2000 Feb; 20(1 Suppl 1):1S-17S. PubMed ID: 10646685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate in psychiatric disorders: literature review and clinical guidelines.
    McElroy SL; Keck PE; Pope HG; Hudson JI
    J Clin Psychiatry; 1989 Mar; 50 Suppl():23-9. PubMed ID: 2494155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the EMA/FDA alerts on the use of effective contraceptive method in women of childbearing age undergoing valproic acid treatment in a long-stay psychiatric center.
    Puig-Molto M; Pol-Yanguas E; Segarra L; Lumbreras B
    Epilepsy Behav; 2020 Jun; 107():107072. PubMed ID: 32278266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate risk form-Surveying 215 clinicians involving 4775 encounters.
    Angus-Leppan H; Moghim MM; Cock H; Kinton L; Synnott Wells M; Shankar R
    Acta Neurol Scand; 2020 Jun; 141(6):483-490. PubMed ID: 32072612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of valproate in psychiatric practice.
    Haddad PM; Das A; Ashfaq M; Wieck A
    Expert Opin Drug Metab Toxicol; 2009 May; 5(5):539-51. PubMed ID: 19409030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
    Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate in Pregnancy: Recent Research and Regulatory Responses.
    Andrade C
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions.
    Gentile S
    CNS Spectr; 2014 Aug; 19(4):305-15. PubMed ID: 24571806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate-induced hyperammonemia in the psychiatric setting: 2 cases.
    Panikkar GP; Gilman SM
    J Clin Psychiatry; 1999 Aug; 60(8):557-9. PubMed ID: 10485644
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.
    Salloum IM; Cornelius JR; Daley DC; Kirisci L; Himmelhoch JM; Thase ME
    Arch Gen Psychiatry; 2005 Jan; 62(1):37-45. PubMed ID: 15630071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
    Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
    BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.